Global Poultry Vaccines Market – Industry Trends and Forecast to 2030

Poultry Vaccines Market Analysis and Size

The increasing poultry population and the growing prevalence of avian diseases are anticipated to enhance the demand for poultry vaccines. There is a surge in demand for poultry vaccines because of the number of zoonotic cases. For instance, as per an article published by the world health organization, a U.S.-based government agency, there is a 64% rise in the number of zoonotic cases in Africa in 2022. Numerous companies operating in the poultry vaccine market are primarily focused on launching new technological solutions to boost their position.

Data Bridge Market Research analyses that the poultry vaccines market, which was USD 2.0 billion in 2022, would rise to USD 3.60 billion by 2030 and is expected to undergo a CAGR of 7.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Poultry Vaccines Market Scope and Segmentation

Market Definition

Poultry vaccine helps prevent a specific disease by considerably accelerating their immune system to develop antibodies to battle against the invading organisms. Poultry vaccines play a major role in poultry disease control and prevention. The majority of poultry-killed vaccines are developed to fight against viral diseases. These vaccines are administered in different forms, such as nasal, oral, ocular, vivo, subcutaneous, and intramuscular. 

Global Poultry Vaccines Market Dynamics

Drivers

• Increasing Research Activities Associated with Poultry vaccines

The growing R&D activities by the major market players for launching poultry vaccines to treat diseases and growing product approvals are expected to increase the market's growth during the forecast period. For instance, Venkys India provides a huge range of poultry vaccines, including the Salmonella polyvalent inactivated vaccine used to prevent and control salmonellosis in breeders, layers, and broilers. OILVAX EDS-76 is also a part of the portfolio of KM Biologics and is very effective against egg drop syndrome. This factor leads to the growth of the market.

• Huge Technological Advancements by Market Players

Several companies operating in the poultry vaccine market are focused on launching new technological solutions to boost their position. For instance, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched the VAXXITEK HVT+IBD+ND vaccine to protect poultry from three types of diseases in 2020. VAXXITEK HVT+IBD+ND boosts a solid immune foundation and offers improved protection against infectious bursal disease (classic and variant kinds), Marek's disease, and Newcastle disease. Thus, this factor help in the market growth.

Opportunities

• Increasing Prevalence of Avian Influenza

As per the data of the World Health Organization, two new outbreaks of highly pathogenic avian influenza (HPAI) A(H5N2) among birds were witnessed. Among 9,578 susceptible birds identified were around 1,819 deaths, and the remaining 7,759 highly infected poultry. Additionally, the CDC has stated that the mortality for this disease is about 90%-100%. This increasing outbreak led to a huge improvement in market growth. Thus, this factor boosts market growth.  

• Increasing Usage of Inactivated Vaccines

Inactivated vaccines have been widely utilized recently, leading to increased market growth. This is because of its easy availability, low cost, and stability advantages over live-attenuated vaccines. They decrease the chances of virus recurrence after vaccination, as it helps to prevent the replication process of pathogens. Furthermore, it provides swine with better immunization with a rapid cell-mediated immune response. Thus, this factor serves as a major factor that increases market growth.

Restraints/Challenges

• Side-Effects of Poultry Vaccines

Numerous effects are associated with poultry vaccine products. Local effects such as swelling of the head, mild discharge from the eye and nose, discomfort and local swelling at the vaccination site, reduced appetite and activity, sneezing, mild fever, and mild coughing. Thus, this factor impedes market growth.  

This poultry vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the poultry vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2020, Boehringer Ingelheim launched the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Marek's Disease, Newcastle Disease, and Infectious Bursal Disease (classic and variant types). Boehringer Ingelheim will produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.

Global Poultry Vaccines Market Scope

The poultry vaccines market is segmented on the basis of product type, dosage form, disease type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Modified or Attenuated (Live)
• Inactivated (Killed)
• Recombinants

Dosage Form

• Liquid Vaccine
• Freeze Dried Vaccine
• Duct

Disease Type

• Newcastle Disease
• Marek's Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Others

Application

• Breeder
• Broiler
• Layer

End User

• Hospitals
• Poultry Vaccination Centres
•  Poultry Firms

Poultry Vaccines Market Regional Analysis/Insights

The poultry vaccines market is analyzed and market size insights and trends are provided by product type, dosage form, disease type, application and end user as referenced above.

The countries covered in the poultry vaccines market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to grow during the forecast period of the poultry vaccines market due to increasing investment in animal health and a persistent rise in demand for poultry-derived products. Also, the huge presence of top poultry production countries, such as China, and a large meat-consuming population, are boosting the market growth.

North America dominates the market in the forecast period due to the increasing technological advancement and the presence of major market players of the market. Other factors which surge the demand for poultry vaccines in this region are the rising government initiatives and huge improvements in animal husbandry practices.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The poultry vaccines market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for poultry vaccines market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the poultry vaccines market. The data is available for historic period 2011-2021.

Competitive Landscape and Poultry Vaccines Market Share Analysis

The poultry vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to poultry vaccines market.

Some of the major players operating in the poultry vaccines market are:

• Boehringer Ingelheim International GmbH. (Germany)
• Zoetis (U.S.)
• Dechra Pharmaceuticals PLC (U.K.)
• Hester Biosciences Limited. (India)
• Merck & Co., Inc. (U.S)
•  Novartis AG (Switzerland)
• Elanco (U.S.)
• Phibro Animal Health Corporation (U.S.)

SKU-59272